Shots:
The CHMP has recommended Imreplys (sargramostim) to treat pts of all ages with Haematopoietic Sub-syndrome of Acute Radiation Syndrome (H-ARS) following myelosuppressive radiation exposure, across the EU, Norway, Iceland, and Liechtenstein
Sargramostim is a recombinant human GM-CSF produced using yeast (S. cerevisiae) expression technology
In 2018, the same formulation was approved by the US…
